REGENERON PHARMACEUTICALS, INC. (REGN)

SEC filing

REGENERON PHARMACEUTICALS, INC.

REGN · CIK 872589

4 · Aug 20, 2026 · EVP Finance CFO Fenimore Christopher R. exercised options for 12.57K shares; reported 4,599 shares

EVP Finance CFO Fenimore Christopher R. exercised options for 12.57K shares; reported 4,599 shares

PRIMARY DOCUMENT

xslF345X06/edgardoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).